The novel catecholamine release-inhibitory peptide catestatin (chromogranin A344-364). Properties and function.
Mahata
S K
SK
Department of Medicine and Center for Molecular Genetics, University of California, and Veterans Affairs, San Diego Healthcare System, San Diego, California 92161-9111, USA.
Mahata
M
M
Livsey Taylor
C V
CV
Taupenot
L
L
Parmer
R J
RJ
O'Connor
D T
DT
D000595:Amino Acid Sequence; D019943:Amino Acid Substitution; D000818:Animals; D001665:Binding Sites; D002395:Catecholamines / Q000378:metabolism*; D002417:Cattle; D053379:Chromogranin A; D002864:Chromogranins / Q000235:genetics / Q000378:metabolism / Q000494:pharmacology / Q000502:physiology*; D008954:Models, Biological; D008969:Molecular Sequence Data; D009538:Nicotine / Q000494:pharmacology; D018733:Nicotinic Antagonists / Q000494:pharmacology; D010446:Peptide Fragments / Q000235:genetics / Q000494:pharmacology / Q000502:physiology*; D011499:Protein Processing, Post-Translational; D051381:Rats; D011978:Receptors, Nicotinic / Q000187:drug effects / Q000502:physiology; D015398:Signal Transduction
D002395:Catecholamines; D053379:Chromogranin A; D002864:Chromogranins; D018733:Nicotinic Antagonists; D010446:Peptide Fragments; D011978:Receptors, Nicotinic; C109084:chromogranin A (344-364); D009538:Nicotine